Advanced in Necrosis

Dr. James S. Gammie

Thoracic Surgery | General Surgery
Johns Hopkins University
600 N Wolfe St, Blalock 266, 
Baltimore, MD 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Advanced in Necrosis
Johns Hopkins University
600 N Wolfe St, Blalock 266, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Gammie is a Thoracic Surgeon and a General Surgeon in Baltimore, Maryland. Dr. Gammie is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Valve Prolapse, Embolectomy, and Heart Bypass Surgery. Dr. Gammie is currently accepting new patients.

His clinical research consists of co-authoring 198 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Thoracic Surgery
General Surgery
Licenses
Specialist in MD
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

JOHNS HOPKINS UNIVERSITY
600 N Wolfe St, Blalock 266, Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Enrollment Status: Recruiting
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drugs: Antiplatelet-only strategy, Anticoagulant+Background antiplatelet therapy
Study Phase: Phase 3
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Long-Term Follow-Up For Participants Of: Evaluation Of Outcomes Following Mitral Valve Repair/Replacement In SMR and Surgical Interventions For MMR Trials
Long-Term Follow-Up For Participants Of: Evaluation Of Outcomes Following Mitral Valve Repair/Replacement In SMR and Surgical Interventions For MMR Trials
Enrollment Status: Active_not_recruiting
Publish Date: July 16, 2025
Intervention Type: Other
Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease
Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Device
Study Phase: Not Applicable
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Randomized Trial of Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Mitral Operation
A Prospective Randomized Trial of Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Mitral Operation
Enrollment Status: Completed
Publish Date: May 08, 2023
Intervention Type: Procedure, Other
Study Phase: Not Applicable
View 8 Less Clinical Trials

198 Total Publications

Preoperative serum LOXL2 levels are elevated in patients with pulmonary hypertension undergoing mitral valve surgery in a prospective observational cohort study.
Preoperative serum LOXL2 levels are elevated in patients with pulmonary hypertension undergoing mitral valve surgery in a prospective observational cohort study.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: July 10, 2025
Similar Doctors
Elite in Necrosis
Dr. David J. Hackam
Pediatric Surgery | Pediatrics | General Surgery
Elite in Necrosis
Dr. David J. Hackam
Pediatric Surgery | Pediatrics | General Surgery

Johns Hopkins University

1800 Orleans St, 
Baltimore, MD 
 (0.1 miles away)
410-955-5000
Languages Spoken:
English, French, Hebrew
See accepted insurances
Accepting New Patients

David Hackam is a Pediatric Surgeon and a Pediatrics provider in Baltimore, Maryland. Dr. Hackam is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Necrotizing Enterocolitis, Necrosis, Short Bowel Syndrome, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Hackam is currently accepting new patients.

Distinguished in Necrosis
Dr. Tanisha M. Osbourne
General Surgery
Distinguished in Necrosis
Dr. Tanisha M. Osbourne
General Surgery

Vohra Post Acute Care Physicians Of The East PA

3800 Lottsford Vista Rd, 
Mitchellville, MD 
 (27.7 miles away)
877-866-7123
Languages Spoken:
English
See accepted insurances

Tanisha Osbourne is a General Surgeon in Mitchellville, Maryland. Dr. Osbourne is rated as a Distinguished provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Peptic Ulcer, Necrosis, Cellulitis, and Spirurida Infections.

Distinguished in Necrosis
Dr. Salvador R. Guerrero
Family Medicine | General Surgery | Vascular Surgery
Distinguished in Necrosis
Dr. Salvador R. Guerrero
Family Medicine | General Surgery | Vascular Surgery

Vohra Post Acute Care Physicians Of The East PA

3800 Lottsford Vista Rd, 
Mitchellville, MD 
 (27.7 miles away)
877-866-7123
Languages Spoken:
English
See accepted insurances

Salvador Guerrero is a General Surgeon and a Vascular Surgeon in Mitchellville, Maryland. Dr. Guerrero is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Peptic Ulcer, Necrosis, Cellulitis, and Stasis Dermatitis and Ulcers.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gammie's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile